Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Hollander

Showing results (91-100 of 246) with videos related to

Pageof 25
Sort By:
Psychiatry Research|October 9, 2009
Cross-cutting issues and future directions for the OCD spectrumEric Hollander, Suah Kim, Ashley Braun, et al.
CNS Spectrums|December 6, 2006
Serotonin dysfunction in pathological gamblers: increased prolactin response to oral m-CPP versus placeboStefano Pallanti, Silvia Bernardi, Leonardo Quercioli, et al.
Current Neuropharmacology|April 28, 2018
Pharmacological Treatment of Body Dysmorphic DisorderKevin Hong, Vera Nezgovorova, Genoveva Uzunova, et al.
CNS Spectrums|June 5, 2007
An open-label trial of divalproex extended-release in the treatment of borderline personality disorderDaphne Simeon, Bryann Baker, William Chaplin, et al.
The Journal of Clinical Psychiatry|February 12, 2005
Dissociation and posttraumatic stress 1 year after the World Trade Center disaster: follow-up of a longitudinal surveyDaphne Simeon, Jennifer Greenberg, Dorothy Nelson, et al.
Journal of Psychopharmacology (Oxford, England)|February 5, 2016
Better than treated as usual: Transcranial magnetic stimulation augmentation in selective serotonin reuptake inhibitor-refractory obsessive-compulsive disorder, mini-review and pilot open-label trialStefano Pallanti, Anna Marras, Luana Salerno, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 11, 2014
Ondansetron augmentation in patients with obsessive-compulsive disorder who are inadequate responders to serotonin reuptake inhibitors: improvement with treatment and worsening following discontinuationStefano Pallanti, Silvia Bernardi, Sarah Antonini, et al.
Journal of Gambling Studies|March 25, 2005
Pharmacological treatments of pathological gamblingEric Hollander, Erica Sood, Stefano Pallanti, et al.
Psychopharmacology|June 27, 2008
Predicting response to opiate antagonists and placebo in the treatment of pathological gamblingJon E Grant, Suck Won Kim, Eric Hollander, et al.
International Journal of Psychiatry in Clinical Practice|October 25, 2013
Characterizing impulsivity profile in patients with obsessive-compulsive disorderBeatrice Benatti, Bernardo Dell'Osso, Chiara Arici, et al.
Pageof 25

Showing results (91-100 of 246) with videos related to

Sort By:
Pageof 25
Psychiatry Research|October 9, 2009
Cross-cutting issues and future directions for the OCD spectrumEric Hollander, Suah Kim, Ashley Braun, et al.
CNS Spectrums|December 6, 2006
Serotonin dysfunction in pathological gamblers: increased prolactin response to oral m-CPP versus placeboStefano Pallanti, Silvia Bernardi, Leonardo Quercioli, et al.
Current Neuropharmacology|April 28, 2018
Pharmacological Treatment of Body Dysmorphic DisorderKevin Hong, Vera Nezgovorova, Genoveva Uzunova, et al.
CNS Spectrums|June 5, 2007
An open-label trial of divalproex extended-release in the treatment of borderline personality disorderDaphne Simeon, Bryann Baker, William Chaplin, et al.
The Journal of Clinical Psychiatry|February 12, 2005
Dissociation and posttraumatic stress 1 year after the World Trade Center disaster: follow-up of a longitudinal surveyDaphne Simeon, Jennifer Greenberg, Dorothy Nelson, et al.
Journal of Psychopharmacology (Oxford, England)|February 5, 2016
Better than treated as usual: Transcranial magnetic stimulation augmentation in selective serotonin reuptake inhibitor-refractory obsessive-compulsive disorder, mini-review and pilot open-label trialStefano Pallanti, Anna Marras, Luana Salerno, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 11, 2014
Ondansetron augmentation in patients with obsessive-compulsive disorder who are inadequate responders to serotonin reuptake inhibitors: improvement with treatment and worsening following discontinuationStefano Pallanti, Silvia Bernardi, Sarah Antonini, et al.
Journal of Gambling Studies|March 25, 2005
Pharmacological treatments of pathological gamblingEric Hollander, Erica Sood, Stefano Pallanti, et al.
Psychopharmacology|June 27, 2008
Predicting response to opiate antagonists and placebo in the treatment of pathological gamblingJon E Grant, Suck Won Kim, Eric Hollander, et al.
International Journal of Psychiatry in Clinical Practice|October 25, 2013
Characterizing impulsivity profile in patients with obsessive-compulsive disorderBeatrice Benatti, Bernardo Dell'Osso, Chiara Arici, et al.
Pageof 25